Sunday November 22 2009 | Biotechnology feed | All feeds
|
|
Raven biotechnologies, inc.
Download detailed PDF Members: Raven's approach creates the optimal starting point for developing a new drug with an increased probability of success in the clinic, within a substantially compressed time frame for drug lead development. The heart of Raven's technical approach is a unique focus on the cell surface—the primary docking point for drugs and diseases—which enables rapid identification of disease-specific antigens and corresponding therapeutic antibody candidates that are not accessible to genomics- or proteomics-based approaches. In the last three years, Raven has introduced its first drug candidate into advanced preclinical development, with more than a dozen other cancer drug candidates under evaluation. Raven's technology has also been validated through a number of development partnerships established with industry-leading companies.
This page has been viewed 416 times since April 2007, the link to the organisation's website has been followed 72 times Recent Search Terms used to find this page: RAVEN biotechnology, target | raven technologies drugs | Raven biotechnologies inc. | Raven biotechnologies Inc | . Search for more companies in South San Francisco Search for more companies in California This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Raven biotechnologies, inc. | |||||||||||||||||||||||||||||||||||||||||||
|